Exhibit
Number
|
|
|
|
3.2
|
|
|
|
Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to the Registrants Registration Statement on Form S-1/A, SEC File No. 333-192984, filed January 28, 2014)
|
|
|
|
|
|
3.4
|
|
|
|
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.4 to the Registrants Registration Statement on Form S-1/A, SEC File No. 333-192984, filed January 28, 2014)
|
|
|
|
|
|
4.1
|
|
|
|
Form of Common Stock Certificate of the Registrant (incorporated by reference to Exhibit 4.1 to the Registrants Registration Statement on Form S-1/A, SEC File No. 333-192984, filed January 28, 2014)
|
|
|
|
|
|
4.2
|
|
|
|
Third Amended and Restated Investor Rights Agreement, dated April 11, 2013, by and among the Registrant and certain of its stockholders (incorporated by reference to Exhibit 4.2 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.1
|
|
|
|
Form of Indemnification Agreement by and between the Registrant and its directors and officers (incorporated by reference to Exhibit 10.1 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.2
|
|
|
|
Eagle Pharmaceuticals, Inc. 2007 Incentive Compensation Plan and Form of Stock Option Agreement thereunder (incorporated by reference to Exhibit 10.2 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013), as amended December 15, 2015 (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K, SEC File No. 001-36306, filed December 21, 2015)
|
|
|
|
|
|
10.3
|
|
|
|
Eagle Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended and restated, and Form of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice thereunder (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K, SEC File No. 001-36306, filed August 10, 2015), as amended with an additional form of Stock Option Agreement (incorporated by reference to Exhibit 10.3 to the Registrants Current Report on Form 8-K, SEC File No. 001-36306, filed December 21, 2015)
|
|
|
|
|
|
10.4
|
|
|
|
Eagle Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 to the Registrants Registration Statement on Form S-1/A, SEC File No. 333-192984, filed January 22, 2014)
|
|
|
|
|
|
10.5
|
|
|
|
Eagle Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.5 to the Registrants Registration Statement on Form S-1/A, SEC File No. 333-192984, filed January 22, 2014)
|
|
|
|
|
|
10.6
|
|
|
|
Employment Agreement by and between the Registrant and Scott Tarriff dated March 8, 2007, as amended (incorporated by reference to Exhibit 10.6 to the Registrants Registration Statement on Form S-1/A, SEC File No. 333-192984, filed January 28, 2014)
|
|
|
|
|
|
10.7
|
|
|
|
Offer Letter by and between the Registrant and Paul Bruinenberg dated September 7, 2011 (incorporated by reference to Exhibit 10.7 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.8
|
|
|
|
Offer Letter by and between the Registrant and Steven Krill dated September 7, 2011 (incorporated by reference to Exhibit 10.8 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.9
|
|
|
|
Offer Letter by and between the Registrant and David Riggs dated November 7, 2013 (incorporated by reference to Exhibit 10.9 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.10
|
|
|
|
Lease Agreement between the Registrant and Mack-Cali Chestnut Ridge L.L.C. dated May 28, 2013, as amended on July 1, 2013 (incorporated by reference to Exhibit 10.10 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013), and as amended on March 16, 2015 (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K , SEC File No. 001-36306, filed March 20, 2015)
|
|
|
|
|
|
10.11
|
|
(a)*
|
|
Development and License Agreement, by and between the Registrant and SciDose, LLC, dated September 24, 2007, as amended March 18, 2008, May 22, 2009 and July 16, 2013 (incorporated by reference to Exhibit 10.11(a) to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.11
|
|
(b)*
|
|
Development and License Agreement, by and between the Registrant and SciDose, LLC, dated June 12, 2007, as amended March 18, 2008, March 25, 2008, December 3, 2008, May 22, 2009 and July 16, 2013 (incorporated by reference to Exhibit 10.11(b) to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013), and as amended on August 5, 2015 (incorporated by reference to Exhibit 10.2 to the Registrants Current Report on Form 8-K, SEC File No. 001-36306, filed August 10, 2015)
|
|
|
|
|
|
10.12
|
|
*
|
|
License and Sublicense Agreement, by and between the Registrant and Lyotropic Therapeutics, Inc., dated October 16, 2008 (incorporated by reference to Exhibit 10.12 to the Registrants Registration Statement on Form S-1, SEC File No. 333-192984, filed December 20, 2013)
|
|
|
|
|
|
10.13
|
|
*
|
|
License and Development Agreement, by and between the Registrant and The Medicines Company, effective as of
|